James P Mackin
CIK 1408470 · President & CEO · last filed 2026-03-04
James P Mackin is a President & CEO who has filed 92 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for AORT, was dated Mar 4, 2026. Across all open-market trades the lifetime net is −$28.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $42.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$42.08M
5
92
-$28.72M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AORT | President & CEO | 965,162 | $28.33 | $27.34M | -$16.83M | 31 | 2026-03-04 |
| CRY | President & CEO | 333,647 | $17.59 | $5.87M | -$11.49M | 33 | 2021-05-04 |
| Wright Medical Group N.V. (WMGI) Delisted | Director | 11,720 | — | — | $0 | 1 | 2019-07-30 |
| Wright Medical Group N.V. (WMGIZ) Delisted | Director | 7,804 | — | — | $0 | 1 | 2018-07-26 |
| MDT | SVP & Pres CRDM | 97,790 | $90.67 | $8.87M | -$398.1K | 14 | 2010-11-02 |
Recent Filings
92 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-04 | AORT | Mixed | +99,061 | -$675.7K | EDGAR |
| 2026-03-03 | AORT | Notice (144) | −17,887 | -$675.7K | EDGAR |
| 2026-03-03 | AORT | Sell (S) | −14,911 | -$567.0K | EDGAR |
| 2026-03-02 | AORT | Notice (144) | −14,911 | -$567.0K | EDGAR |
| 2026-02-25 | AORT | Mixed | +62,132 | -$1.29M | EDGAR |
| 2026-02-24 | AORT | Notice (144) | −13,936 | -$497.4K | EDGAR |
| 2026-02-23 | AORT | Notice (144) | −20,962 | -$787.9K | EDGAR |
| 2025-12-04 | AORT | Mixed | — | -$489.8K | EDGAR |
| 2025-12-03 | AORT | Notice (144) | −30,921 | -$1.41M | EDGAR |
| 2025-12-03 | AORT | Mixed | — | -$492.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.